COMMUNIQUÉS West-GlobeNewswire

Avivagen Announces CEO Letter to Shareholders
17/01/2019
OTTAWA, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce its 2019 letter to shareholders by Chairman and interim CEO Kym Anthony. To our shareholders: As the consumer, [...]
Interim report September 1, 2018 – November 30, 2018
17/01/2019
Company announcement no.01/2019 Report attached For further information, please contact: Martin Riise, Head of Investor Relations, Tel: +45 53 39 22 50 Camilla Lercke, Head of Media Relations, Tel: +45 53 39 23 84 About [...]
PledPharma presents PledOx®’s phase III program at the Gastrointestinal (GI) Cancers Symposium
17/01/2019
Stockholm, January 17, 2019. PledPharma AB (publ) announces that the company’s global phase III program, POLAR, has been accepted for a poster presentation during the Gastrointestinal (GI) Cancers Symposium in January [...]
Nicox : Point d'activité et résumé financier du quatrième trimestre 2018
17/01/2019
Communiqué de presse Nicox : Point d'activité et résumé financier du quatrième trimestre 2018 ................................................. Augmentation de 47% du nombre total de prescriptions de VYZULTA ® pour le [...]
DBV Technologies: Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
17/01/2019
AMF REGULATED INFORMATION Montrouge, France, January 17, 2019 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), [...]
DBV Technologies : Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
17/01/2019
Informations Réglementées Montrouge, France, le 17 janvier (7h30 CET), 2019 Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : DBVT [...]
Nicox Fourth Quarter 2018 Business Update and Financial Highlights
17/01/2019
Press Release Nicox Fourth Quarter 2018 Business Update and Financial Highlights ............................................... Total VYZULTA ® prescriptions for the fourth quarter 2018 up 47% compared to the third [...]
Spineway: 2018 revenue of €6.5M
17/01/2019
In thousands of euros 2017 2018* Annual revenue 9 137 6 513 * Unaudited figures The SPINEWAY Group posted a total 2018 revenue of €6 513K that is in line with the trend set by the previous quarters (-29%) pursuant to [...]
SPINEWAY : Chiffre d’affaires 2018 de 6,5 M€
17/01/2019
En milliers d'euros 2017 2018* CA annuel 9 137 6 513 * Chiffres non audités Le groupe SPINEWAY totalise sur l’année 2018 un chiffre d’affaires de 6 513 k€ qui s’inscrit dans la tendance des trimestres précédents (- 29 [...]
Golden Leaf Holdings Announces Termination of Agreement to Acquire a multi-use “Sweet 16” license and certain other assets in San Jose, California
16/01/2019
PORTLAND, Ore., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]
Assure Holdings Announces Option Issuance
16/01/2019
DENVER, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announces that further to a board meeting held [...]
Golden Leaf Holdings Announces Termination of Agreement to Acquire the Assets of Tahoe Hydroponics
16/01/2019
PORTLAND, Ore., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]
Publication in ImmunoHorizons Highlights the Role of IL-27 in Upregulation of Multiple Checkpoint Proteins
16/01/2019
- Expression of IL-27 shown to contribute to upregulation of PD-L1, LAG-3, CTLA-4, and TIGIT - Surface Oncology will submit an IND for SRF388, a first-in-class IL-27 antibody, in Q4 2019 CAMBRIDGE, Mass., Jan. 16, 2019 [...]
MannKind Announces Direct Purchase Insulin Program Providing Afrezza® for as low as $4 a Day
16/01/2019
More than 65,000 patients currently pay cash for their daily insulin each month WESTLAKE VILLAGE, Calif., Jan. 16, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), a company focused on the development and [...]
Adamis’ Commercial Partner Launches SYMJEPI™ (epinephrine) in the US
16/01/2019
SAN DIEGO, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that its marketing and commercial partner, Sandoz Inc. (Sandoz), a Novartis division, has launched SYMJEPI [...]
Inspire Medical Systems, Inc. Announces a Positive Coverage Policy Issued by Horizon Blue Cross Blue Shield of New Jersey
16/01/2019
MINNEAPOLIS, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Sharecare names finalists for inaugural Sharecare Awards
16/01/2019
Public voting open for Sharing Care Award until Jan. 25; all Sharecare Award winners revealed on March 14 at special event in Atlanta and via Facebook Live ATLANTA, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Sharecare, the [...]
HTG Launches HTG EdgeSeq Reveal
16/01/2019
HTG EdgeSeq Reveal is a new software product to analyze HTG EdgeSeq Precision Immuno‑Oncology Panel data TUCSON, Ariz., Jan. 16, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life [...]
Pangu BioPharma (an aTyr Pharma Subsidiary) and The Hong Kong University of Science and Technology Recognized for Pioneering Work Leading to New Investigational Therapeutic for Lung Disease
16/01/2019
Researchers from The Hong Kong University of Science and Technology credited with important translational science and early discovery work Significant opportunity to replicate collaborative model to develop pipeline of [...]

Pages